EPICARDIAL OBESITY AND A RANGE OF METABOLIC RISK FACTORS RELATION WITH THE PREVALENCE INDEX OF CORONARY ATHEROSCLEROSIS
https://doi.org/10.15829/1728-8800-2015-2-35-40
Abstract
Aim. To assess the relation of epicardial fat tissue thickness (EFTT) and other metabolic risk factors with the index of coronary atherosclerosis Spread (CASI) in obese patients. Material and methods. Totally 186 men included (54,4±9,1 y.o.) with coronary heart disease (CHD) and obesity. By the results of coronary arteriography we calculated Gensini Score of CASI. All patients underwent laboratory tests with the measurement of basic and additional metabolic risk factors and echocardiography with EFFT measurement. Results. By the data of regression analysis we selected 7 predictors significantly related to EFTT: CASI (β=0,390), resistine (β=0,453), glucose (β=152), adiponectine (β=-0,175), high density lipoproteides cholesterol (β=-0,138), interleukine-6 (β=0,118), and tumor necrosis factor-α (β=0,117). Measurement of the predictors values led in 52,1% to the changes of CASI value (R²=0,521). Conclusion. In obese patients the assessment of the parameters described makes possible to circle a high risk group for unsymptomatic CHD forms with the aim for on-time investigation of patients and for early preventive interventions.
About the Authors
G. A. Chumakova
Altay State Medical University, Barnaul, Russia; FSBI SRI of Complex Problems of Cardiovascular Diseases SD RAMS. Kemerovo, Russia
Russian Federation
Russian Federation
N. G. Veselovskaya
FSBI SRI of Complex Problems of Cardiovascular Diseases SD RAMS. Kemerovo, Russia; Altay Regional Cardiological Dispensary. Barnaul, Russia
Russian Federation
Russian Federation
A. V. Ott
Altay Regional Cardiological Dispensary. Barnaul, Russia
Russian Federation
Russian Federation
O. V. Gritsenko
FSBI SRI of Complex Problems of Cardiovascular Diseases SD RAMS. Kemerovo, Russia; Altay Regional Cardiological Dispensary. Barnaul, Russia
Russian Federation
Russian Federation
References
1. Gruberg L, Weissman NJ, Waksman R et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? JACC 2002; 39(4): 578-84.
2. Chumakova GA, Veselovskaya NG, Kozarenko AA. Epicardial fat depo: morphology, diagnostics, clinical value. Serdze 2011; 10(3): 143-7. Russian (Чумакова Г. А., Веселовская Н. Г., Козаренко АА. Эпикардиальное жировое депо: морфология, диагностика, клиническое значение. Сердце 2011; 10(3): 143-7).
3. Iacobellis G, Willens HJ. Echocardiographic Epicardial Fat: A Review of Research and Clinical Applications. JASE 2009; 22(12): 1311-9.
4. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51(3): 606.
5. Ahn SG, Lim HS, Joe DY Relationship of epicardial adipose tissue by echocardiography to coronary artery disease. Heart 2008; 94(3): 7-13.
6. Jeong JW, Jeong MH, Yun KH, et al. Echocardiographic epicardial fat thickness and coronary artery disease. Circ J 2007; 71(4): 536-9.
7. Doesch C, Suselbeck T, Haghi D. The Relationship between the Severity of Coronary Artery Disease and Epicardial Adipose Tissue Depends on The Left Ventricular Function. PLoS One 2012; 7(11): 48330.
8. Bonora E, Kiechl S, Willeit J, et al. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population: the Bruneck Study. Diabetes Care 2007; 30: 318-24.
9. Fan J, Watanabe T. Inflammatory reactions in the pathogenesis of atherosclerosis. J Atherosclerosis and Thrombosis 2003; 10(2): 63-71.
10. Beltowski J. Role of leptin in blood pressure regulation and arterial hypertension. J Hypertens 2006; 24(5): 789-801.
11. Calabro P, Samudio I, Willerson JT. Resistin promotes smooth muscle cell proliferation through activation of extracellular signal regulated kinase 1/2 and phosphatidfylinositol 3-kinase pathways. Circulation 2004; 110(21): 3335-40.
12. Rothenbacher D, Brenner H, Marz W. Adiponectin, risk of coronary heart disease and correlations. Eur Heart J 2005; 26(16): 1640-6.
13. Weiss TW, Arnesen H, Seljeflot I. Components of the Interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness. Metabolism 2013; 26: 123-8.
14. Minutello RM, Chou ET, Hong MK, et al. Impact of body mass index on in-hospital outcomes following percutaneous coronary intervention (report from the New York State Angioplasty Registry). Am J Cardiol 2004; 93(10): 1229-32.
15. Mazurek T, Zhang L, Zalewski A, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108(20): 2460-6.
16. Ding J, Hsu FC, Harris TB. The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA)1,2,3. Am J Clin Nutr 2009; 90(3): 499-504.
17. Tellides G. Periadventitial fat. Arch Pathol Lab Med 2007; 131(3): 346-7.
Review
For citations:
Chumakova G.A., Veselovskaya N.G., Ott A.V., Gritsenko O.V. EPICARDIAL OBESITY AND A RANGE OF METABOLIC RISK FACTORS RELATION WITH THE PREVALENCE INDEX OF CORONARY ATHEROSCLEROSIS. Cardiovascular Therapy and Prevention. 2015;14(2):35-40. (In Russ.) https://doi.org/10.15829/1728-8800-2015-2-35-40
Views:
801
Email this article 
